肺炎支原体感染引发小儿哮喘临床症状及治疗分析

Clinical symptoms of children with Mycoplasma pneumoniae infection-induced asthma and treatment measures

目的分析肺炎支原体感染引发小儿哮喘临床资料,并探讨治疗方法,为提高疗效提供依据。方法以2012年3月-2013年3月确诊的小儿哮喘患儿80例作为研究对象,其中40例肺炎支原体感染引发的哮喘患儿作为观察组,40例非肺炎支原体感染诱发哮喘的患儿为对照组,分别对两组患儿临床症状进行观察记录,并进行分析。结果 40例观察组患儿发热33例占82.5%,其中体温>37.3℃17例占42.5%,体温>38℃14例占35.0%,体温>39℃2例占5.0%;40例对照组患儿发热18例占45.0%,其中体温>37.3℃14例占35.0%,体温>38℃4例占10.0%;观察组与对照组患儿的喘息发生特点、发热、肺部感染等临床表现不同。结论观察组患儿比对照组患儿的症状更加严重,在对肺炎支原体感染引发哮喘的患儿进行治疗时应采用大环内酯类抗菌药物、支气管扩张剂和糖质激素吸入治疗相结合的方式,并辅以日常护理治疗。

OBJECTIVE To analyze the clinical data of the children with asthma induced by Mycoplasma pneumoni‐ae infection and explore the treatment measures so as to provide guidance for the improvement of efficacy . METHODS From Mar 2012 to Mar 2013 ,a total of 80 children with conformed asthma were recruited as the study objects and were divided into the observation group with 40 cases （the children with M .pneumoniae infection‐in‐duced asthma） and the control group with 40 cases （the children with non‐M .pneumoniae infection‐induced asth‐ma）;the clinical symptoms of the two groups of children were observed and recorded .RESULTS Of the 40 children in the observation group ,33 （82 .5% ） cases were with fever ,among whom the children with the body temperature more than 37 .3 ℃ accounted for 42 .5% （17 cases） ,the children with the body temperature more than 38 ℃35 .0% （14 cases） ,the children with the body temperature more than 39 ℃ 5 .0% （2 cases） .Of the 40 children in the control group ,18 （45 .0% ） cases were with fever ,among whom the children with body temperature more than 37 .3 ℃ accounted for 35 .0% （14 cases） ,the children with the body temperature more than 38℃ 10 .0% （4 ca‐ses） .The clinical manifestations such as the wheezing ,fever ,and pulmonary infections varied between the obser‐vation group and the control group .CONCLUSION The clinical symptoms of the observation group are more severe than those of the control group .For the treatment of the children with M .pneumoniae infection‐induced asthma , it is necessary to use macrolides and bronchodilators in combination with corticosteroids sugar inhalation ,with the daily care supplemented .